Search by Drug Name or NDC
NDC 69238-1596-08 Aminocaproic acid 0.25 g/mL Details
Aminocaproic acid 0.25 g/mL
Aminocaproic acid is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is AMINOCAPROIC ACID.
MedlinePlus Drug Summary
Aminocaproic acid is used to control bleeding that occurs when blood clots are broken down too quickly. This type of bleeding may occur during or after heart or liver surgery; in people who have certain bleeding disorders; in people who have cancer of the prostate (a male reproductive gland), lung, stomach, or cervix (opening of the uterus); and in pregnant women experiencing placental abruption (placenta separates from the uterus before the baby is ready to be born). Aminocaproic acid is also used to control bleeding in the urinary tract (the organs in the body that produce and excrete urine) that may occur after prostate or kidney surgery or in people who have certain types of cancer. Aminocaproic acid should not be used to treat bleeding that is not caused by faster than normal clot breakdown, so your doctor may order tests to find the cause of your bleeding before you begin your treatment. Aminocaproic acid is in a class of medications called hemostatics. It works by slowing the breakdown of blood clots.
Related Packages: 69238-1596-08Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Aminocaproic Acid
Product Information
| NDC | 69238-1596 |
|---|---|
| Product ID | 69238-1596_2b9785d5-ea90-465b-a9f5-2c70e578799a |
| Associated GPIs | 84100010002060 |
| GCN Sequence Number | 006503 |
| GCN Sequence Number Description | aminocaproic acid SOLUTION 250 MG/ML ORAL |
| HIC3 | M9D |
| HIC3 Description | ANTIFIBRINOLYTIC AGENTS |
| GCN | 25580 |
| HICL Sequence Number | 002801 |
| HICL Sequence Number Description | AMINOCAPROIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Aminocaproic acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aminocaproic acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 0.25 |
| Active Ingredient Units | g/mL |
| Substance Name | AMINOCAPROIC ACID |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212780 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69238-1596-08 (69238159608)
| NDC Package Code | 69238-1596-8 |
|---|---|
| Billing NDC | 69238159608 |
| Package | 236.5 mL in 1 BOTTLE, PLASTIC (69238-1596-8) |
| Marketing Start Date | 2019-08-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |